Chemotherapy Alone vs. Chemotherapy Plus High Dose Multiple Antioxidants in Patients with Advanced Non Small Cell Lung Cancer

Journal of the American College of Nutrition

Volumn 24, Issue 1, 2005, Pages 16-21

  Pathak, Ashutosh Kumar ^a   Bhutani, Manisha ^a   Sharma, Atul ^a   Pathak, Raminder ^a   Bhardwaj, Narendra K ^a   Kochupillai, Vinod ^a   Guleria, Randeep ^a   Mohan, Anant ^a   Bal, Sabyasachi ^a   Mohanti, Bidhu K ^a   Prasad, Kedar N ^b  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Antioxidants; Beta carotene; Chemotherapy; Lung cancer; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBOPLATIN; FREE RADICAL; PACLITAXEL;

ADULT; AGED; ARTICLE; CALCULATION; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CELL PROTECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CARCINOMA, NON-SMALL-CELL LUNG; DRUG SYNERGISM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; VITAMIN E;

EID: 20244384114     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2005.10719438     Document Type: Article

References (32)

1. Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-66, 2001.
2. Non Small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311: 899-909, 1995.
3. Smith W, Khuri FR: The care of the lung cancer patient in the 21st century: a new age. Semin Oncol. 31(2 Suppl 4): 11-15, 2004.
4. Prasad KN, Sinha PK, Ramanujam M, Sakamoto A: Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci U S A 76: 829-832, 1979.
5. Prasad K: Modulation of the effect of tumor therapeutic agents by vitamin C. Life Sci 27: 275-280, 1980.
6. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA: Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 22: 233-245, 1994.
7. Prasad K, Kumar R: Effect of individual antioxidant vitamins alone and in combination on growth and differentiation of human non-tumorigenic and tumorigenic parotid acinar cells in culture. Nutr Cancer 26: 11-19, 1996.
8. Chabner BA, Longo DL: –Cancer Chemotherapy and Biotherapy,— 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
9. Klastersky J: Side effects of Ifosfamide. Oncology 65(Suppl 2): 7-10, 2003.
10. Hussain AE, Blakley BW, Nicolas M, Balderston J: Assessment of the protective effects of amifostine against cisplatin-induced toxicity. J Otolaryngol 32: 294-297, 2003.
11. Pathak AK, Singh N, Khanna N, Reddy VG, Prasad KN, Kochupillai V: Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung cancer H520 Cells. J Am Coll Nutr 21: 416-421, 2002.
12. Carboplatin dosing formulae. Gender bias and the use of creatinine-based methodologies. Eur J Cancer 38: 11-16, 2002.
13. Prasad KN, Kumar A, Kochupillai V, Cole WC: High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18: 13-25, 1999.
14. Cancer Therapy Evaluation Program: Common toxicity criteria, version 2.0. Bethesda, Md; National Cancer Institute, 1998.
15. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-458, 1958.
16. Ettinger DS: Overview and state of the art in the management of lung cancer. Oncology (Huntingt) 18(7 Suppl 4): 3-9, 2004.
17. Haura EB: Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies. Cancer Control 8: 326-36, 2001.
18. Bonomi P, Kim K, Chang A, Johnson D: Phase III trial comparingetoposide & cisplatin versus taxol with cisplatin-G-CSF versus taxol-cisplatin in advanced non small cell lung cancer. An eastern cooperative oncology group (ECOG) trial (Abstr). Proc Am Soc Clin Oncol: Abstract No 1145, 1996.
19. Gatzemeier U, Von Pawel J, Gottfried M, Velde GPM, Mattson K, DeMarinis F, Harper P, Salvati F, Robinet G, Lucenti A, Bogaerts J, Winograd B, Gallant G: Phase III comparative study of high dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non small cell lung cancer (Abstr). Proc Am Soc Clin Oncol: Abstract No 1748, 1998.
20. Belani CP, Natale RB, Lee JS, Socinski M, Robert F, Waterhouse D, Rowland K, Ansari R, Lilenbaum R, Sridhar K: Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/ paclitaxel in advanced and metastatic non small cell lung cancer (Abstr). Proc Am Soc Clin Oncol: Abstract No 1751, 1998.
21. Kelly K, Crowley J, Bunn PA, Livingston RB, Gandara DR: A randomized phase III trial of paclitaxel plus carboplatin versus vinorelbin plus cisplatin in untreated advanced non small cell lung cancer: a southwest oncology group (SWOG) trial (Abstr). Proc Am Soc Clin Oncol: Abstract No 1777, 1999.
22. Seifter E, Rettura A, Padawar J, Levenson SM: Vitamin A and-carotene as adjunctive therapy to tumor excision, radiation therapy and chemotherapy. In Prasad KN (ed): –Vitamins, Nutrition and Cancer.— Basel: Karger, pp 1-19, 1984.
23. Jaakkola K, Lahteenmaki P, Laakso J, Harju E, Tykka H, Mahlberg K: Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with smallcell lung cancer. Anticancer Res 12: 599-606, 1992.
24. Drisko JA, Chapman J, Hunter VJ: The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr. 22: 118-23, 2003.
25. Lockwood K, Moesgaard S, Hanioka T, Folkers K: Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 15(Suppl): 231-240, 1994.
26. Clemens MR, Waladkhani AR, Bublitz K, Ehninger G, Gey KF: Supplementation with antioxidants prior to bone marrow transplantation. Wien Klin Wochenschr 109: 771-776, 1997.
27. Lamm DL, Riggs DR, Shriver JS, et al: Megadose vitamins in bladder cancer: A double-blind clinical trial. J Urol 151: 21-26, 1994.
28. Wang YM, Madanat FF, Kimball JC, Gleiser CA, Ali MK, Kaufman MW, van Eys J: Effect of vitamin E against adriamycininduced toxicity in rabbits. Cancer Res 40: 1022-1027, 1980.
29. Delanian S: Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Brit J Radiol 71: 892-894, 1998.
30. Cole WC, Prasad KN: Heterogeneity of commercial-carotene preparations: correlation with biological activities. In Prasad KN, Cole WC (eds): –Cancer and Nutrition.— Amsterdam: IOS Press, pp 99-104, 1998.
31. Carini R, Poli G, Dianzani MU, Maddix SP, Slater TF, Cheeseman KH: Comparative evaluation of the amount of the antioxidant activity of alpha-tocopherol, alpha-tocopherol polyethylene glycol 1000 succinate and alpha-tocopherol succinate in isolated hepatocytes and liver microsomal suspensions. Biochem Pharmacol 39: 1597-1601, 1990.
32. Wycherly BJ, Moak MA, Christensen MJ: High dietary intake of sodium selenite induces oxidative DNA damage in rat liver. Nutr Cancer 48: 78-83, 2004.